F
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G69.1 KBF-star Therapeutics, Inc.Mar 17, 4:23 PM ET·0000935836-23-000333
- 8-K334.0 KBF-star Therapeutics, Inc.Mar 9, 8:27 AM ET·0001193125-23-065376
- 8-K175.3 KBF-star Therapeutics, Inc.Mar 7, 9:08 AM ET·0001193125-23-062273
- 8-K155.3 KBF-star Therapeutics, Inc.Mar 6, 9:31 AM ET·0001193125-23-060860
- 8-K154.4 KBF-star Therapeutics, Inc.Feb 23, 8:45 AM ET·0001193125-23-045713
- SC 13G/A85.4 KBF-star Therapeutics, Inc.Feb 14, 4:06 PM ET·0001104659-23-021574
- SC 13G/A85.4 KBF-star Therapeutics, Inc.Feb 14, 4:02 PM ET·0001104659-23-021509
- 8-K155.3 KBF-star Therapeutics, Inc.Feb 9, 9:01 AM ET·0001193125-23-029317
- 8-K154.6 KBF-star Therapeutics, Inc.Feb 1, 8:44 AM ET·0001193125-23-020893
- 8-K153.6 KBF-star Therapeutics, Inc.Dec 30, 8:37 AM ET·0001193125-22-315174
Insiders
10Tickers
No tickers on record
Addresses
business
35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS
CAMBRIDGE, X0, CB22 3AT
mailing
35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS
CAMBRIDGE, X0, CB22 3AT
Former Names
- Spring Bank Pharmaceuticals, Inc.2020-11-09